News
A judge denied compounders' request to keep making off-brand Wegovy and Ozempic after the FDA removed semaglutide from its shortage list.
Stockhead on MSN10m
Health Check: We’re a goer says Aroa, with US tariffs unlikely to be a ‘major headwind’NZ based wounds management house Aroa Biosurgery says the US tariff imposed on its products should be much less than ... Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback